Earlier intervention in the management of hypercholesterolemia: what are we waiting for?
Level V
Where this comes from
- Record sourced from PubMed, PMID 20705219.
- Also identified by DOI 10.1016/j.jacc.2009.12.057.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The thesis advanced here is that we are initiating treatment of hypercholesterolemia (and other risk factors) too late in life. Initiating treatment at, for example, age 30 years instead of age 60 years might very well prevent not just 30% of events, as in the 5-year statin trials, but perhaps as many as 60%.
Medical subject headings
- Hypercholesterolemia